The impact of innate immune response on the efficacy of oncolytic viruses

Oncolytic viruses represent a promising class of immunotherapeutic agents for the treatment of malignant tumors. The proposed mechanism of action of various oncolytic viruses has initially been explained by the ability of such viruses to selectively lyse tumor cells without damaging healthy ones. Re...

Full description

Saved in:
Bibliographic Details
Main Authors: Kirill N. Trachuk, Nikolai B. Pestov, Yulia K. Biryukova, Nadezhda M. Kolyasnikova
Format: Article
Language:English
Published: Central Research Institute for Epidemiology 2024-12-01
Series:Вопросы вирусологии
Subjects:
Online Access:https://virusjour.crie.ru/jour/article/viewFile/16692/939
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591248869818368
author Kirill N. Trachuk
Nikolai B. Pestov
Yulia K. Biryukova
Nadezhda M. Kolyasnikova
author_facet Kirill N. Trachuk
Nikolai B. Pestov
Yulia K. Biryukova
Nadezhda M. Kolyasnikova
author_sort Kirill N. Trachuk
collection DOAJ
description Oncolytic viruses represent a promising class of immunotherapeutic agents for the treatment of malignant tumors. The proposed mechanism of action of various oncolytic viruses has initially been explained by the ability of such viruses to selectively lyse tumor cells without damaging healthy ones. Recently, there have emerged more studies determining the effect of the antiviral immunostimulating mechanisms on the effectiveness of treatment in cancer patients. Stimulation of innate immune cells by an oncolytic virus can initiate an adaptive antitumor immune response, yet at the same time, the antiviral mechanisms of the immune system can limit the spread of the virus, thereby reducing its effectiveness. Thus, the success of the clinical application of the oncolytic viruses directly depends on the three key components: tumor immunosuppression, antiviral responses, and antitumor immune responses. The review presents current data on the influence of pattern recognition receptors on the effectiveness of oncolytic viruses.
format Article
id doaj-art-9fd8cf9fdded445eb1891b84b9d724ef
institution Kabale University
issn 0507-4088
2411-2097
language English
publishDate 2024-12-01
publisher Central Research Institute for Epidemiology
record_format Article
series Вопросы вирусологии
spelling doaj-art-9fd8cf9fdded445eb1891b84b9d724ef2025-01-22T15:18:43ZengCentral Research Institute for EpidemiologyВопросы вирусологии0507-40882411-20972024-12-0169647948810.36233/0507-4088-2751251The impact of innate immune response on the efficacy of oncolytic virusesKirill N. Trachuk0https://orcid.org/0000-0002-2061-0274Nikolai B. Pestov1https://orcid.org/0000-0002-9973-0120Yulia K. Biryukova2https://orcid.org/0000-0002-5804-4001Nadezhda M. Kolyasnikova3https://orcid.org/0000-0002-9934-2582Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis)Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis)Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis)Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis)Oncolytic viruses represent a promising class of immunotherapeutic agents for the treatment of malignant tumors. The proposed mechanism of action of various oncolytic viruses has initially been explained by the ability of such viruses to selectively lyse tumor cells without damaging healthy ones. Recently, there have emerged more studies determining the effect of the antiviral immunostimulating mechanisms on the effectiveness of treatment in cancer patients. Stimulation of innate immune cells by an oncolytic virus can initiate an adaptive antitumor immune response, yet at the same time, the antiviral mechanisms of the immune system can limit the spread of the virus, thereby reducing its effectiveness. Thus, the success of the clinical application of the oncolytic viruses directly depends on the three key components: tumor immunosuppression, antiviral responses, and antitumor immune responses. The review presents current data on the influence of pattern recognition receptors on the effectiveness of oncolytic viruses.https://virusjour.crie.ru/jour/article/viewFile/16692/939reviewoncolytic virusesthe innate immune responseprrs
spellingShingle Kirill N. Trachuk
Nikolai B. Pestov
Yulia K. Biryukova
Nadezhda M. Kolyasnikova
The impact of innate immune response on the efficacy of oncolytic viruses
Вопросы вирусологии
review
oncolytic viruses
the innate immune response
prrs
title The impact of innate immune response on the efficacy of oncolytic viruses
title_full The impact of innate immune response on the efficacy of oncolytic viruses
title_fullStr The impact of innate immune response on the efficacy of oncolytic viruses
title_full_unstemmed The impact of innate immune response on the efficacy of oncolytic viruses
title_short The impact of innate immune response on the efficacy of oncolytic viruses
title_sort impact of innate immune response on the efficacy of oncolytic viruses
topic review
oncolytic viruses
the innate immune response
prrs
url https://virusjour.crie.ru/jour/article/viewFile/16692/939
work_keys_str_mv AT kirillntrachuk theimpactofinnateimmuneresponseontheefficacyofoncolyticviruses
AT nikolaibpestov theimpactofinnateimmuneresponseontheefficacyofoncolyticviruses
AT yuliakbiryukova theimpactofinnateimmuneresponseontheefficacyofoncolyticviruses
AT nadezhdamkolyasnikova theimpactofinnateimmuneresponseontheefficacyofoncolyticviruses
AT kirillntrachuk impactofinnateimmuneresponseontheefficacyofoncolyticviruses
AT nikolaibpestov impactofinnateimmuneresponseontheefficacyofoncolyticviruses
AT yuliakbiryukova impactofinnateimmuneresponseontheefficacyofoncolyticviruses
AT nadezhdamkolyasnikova impactofinnateimmuneresponseontheefficacyofoncolyticviruses